EUVIMEDEUVIMED entdecken
Crossref

The Role of Osteopontin Expression in the Prognosis of Malignant Melanoma

Serkan Degirmencioglu

Novel Approaches in Cancer Study · 2018

DOI: 10.31031/nacs.2018.01.000511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Novel Approaches in Cancer Study, 2018. Verfasst von Serkan Degirmencioglu. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A total of 26 cases of melanoma, including 13 metastatic and 13 non-metastatic cases, diagnosed in the Department of Pathology at the Pamukkale University, were included in this study. An osteopontin antibody was applied immunohistochemically to the blocks of the cases, including the primary and metastatic tumors. The degree of osteopontin expression was expressed semi-quantitatively as none/mild/ intermediate/severe, and the results were compared using parameters, such as histopathological characteristics (location, depth, cellular type, number of mitoses, number of positive lymph nodes, number of total lymph nodes and presence of ulcer), age, gender, stage, survival rate and progression-free survival, and the analysis were performed using the SPSS 16.0 package program.

Zitieren

APA

Degirmencioglu, S. (2018). The Role of Osteopontin Expression in the Prognosis of Malignant Melanoma. Novel Approaches in Cancer Study. https://doi.org/10.31031/nacs.2018.01.000511

Vancouver

Degirmencioglu S. The Role of Osteopontin Expression in the Prognosis of Malignant Melanoma. Novel Approaches in Cancer Study. 2018. doi:10.31031/nacs.2018.01.000511

BibTeX
@article{Degirmencioglu2018,
  author = {Degirmencioglu, Serkan},
  title = {The Role of Osteopontin Expression in the Prognosis of Malignant Melanoma},
  journal = {Novel Approaches in Cancer Study},
  year = {2018},
  doi = {10.31031/nacs.2018.01.000511}
}
Kostenlos starten →